LWA
SPPI

Lenox Wealth Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Lenox Wealth Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$1K – 664
2020
Q2 		$1K Buy
+200
New +$583 ﹤0.01% 570

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lenox Wealth Advisors's SPPI Position: Q3 2020 in Review

Lenox Wealth Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 200 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in SPPI in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Lenox Wealth Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Lenox Wealth Advisors sold 200 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2020 and held it in 1 quarter.
  • Lenox Wealth Advisors's Spectrum Pharmaceuticals Inc position peaked at $1K in Q2 2020.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Lenox Wealth Advisors's 13F filing for Q3 2020, filed 7 Oct 2020.